NDRA

3.5753.38%
MJ

Michael John Harsh

Independent Director

Mr. Michael John Harsh, also known as Mike, is Advisor at City Labs, Inc. Mr. Harsh serves as Advisor at Tau Ventures, Llc. He focuses on healthcare. He is a Co-Founder and Chief Product Officer of Terapede Systems Inc. Prior to co-founding Terapede Systems in 2015. He is a Portfolio Executive for the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) COVID-19 Response Program. He has been a Member of the Scientific Advisory Board of Phoenix LLC (formerly, Phoenix Nuclear labs). Mr. Harsh has extensive experience in healthcare technology, focused on diagnostic imaging. He is extraordinarily fluent in the complex processes of transforming high-potential platform technologies into successful medical diagnostic products. At GE, his technical acumen, big-picture thinking and the ability to form and sustain important relationships propelled his rise to the C-suite. He served as the Chief Technology Officer and Vice President of GE Healthcare Limited, leading its global science and technology organization and research and development teams in diagnostics, healthcare IT and life sciences. He began his career at GE in 1979 as an Electrical Design Engineer in nuclear imaging and subsequently held numerous design and engineering management positions with X-Ray, Ultrasound, MR and Information Technologies. Before returning to GE Healthcare, he served as Vice President of Technology for GE Enterprise Solutions. From 2000 to 2004, he served as General Manager of Global MR Engineering for GE Healthcare. From 1998 to 2000, he served as General Manager of Global Technology at GE Healthcare Information Technologies. He served as Vice President of Technology for GE Industrial at General Electric Company since October 2006. In 2004, he was named Global Technology Leader – Imaging Technologies Lab at the GE Global Research Center, where he led the research for imaging technologies across the company as well as the research associated with computer visualization/image analysis and superconducting systems. He led the Engineering division for GE Industrial and Enterprise Solutions from 2006 to 2009. He was named an Officer of the General Electric Company in November 2006. He has been Independent Director of Compute Health Acquisition Corp since February 2021. He served as a Member of the Board of Directors of FloDesign Sonics since 2015 until its acquisition by MilliporeSigma, a division of the Merck Group and a Consultant to start-ups in the medical device industry. Mr. Harsh serves as a Director of EmOpti, Inc., since 2015. He served as a Non-Executive Director at Imagion Biosystems Limited since February 28, 2017 until August 01, 2024. He has been an Independent Director of ENDRA Life Sciences Inc. since 2015. He served as a Member of Science and Technology Advisory Board at Manhattan Scientifics, Inc. since March 2016 until 2020. He is a Member the Radiological Society of North America (“RSNA”) and Research & Education Foundation Board of Trustees. He is also a McKinsey Senior Advisor and a consultant in the medical device industry. He is a Member of the Marquette University National Advisory Council to the College of Engineering. In 2008, he was elected to the America Institute for Medical and Biological Engineering (AIMBE) College of Fellows for his contributions to medical and biological engineering. He holds numerous U. S. patents in the field of medical imaging and instrumentation. In 2008, he was elected to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows for his significant contributions to the medical and biological engineering field. Mr. Harsh is a graduate of Marquette University in Milwaukee, Wisconsin, where he earned a BS in Electrical Engineering. He is Director of Magnetic Insight, Inc. from April 2023.

Positions